Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Array BioPharma Inc. Sank 13.5% in May
Why Array BioPharma Inc. Sank 13.5% in May
Why Array BioPharma Inc. Sank 13.5% in May
Submitted by
admin
on June 7, 2017 - 10:08am
Source:
Motley Fool
News Tags:
Array Biopharma
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
binimetinib
encorafenib
Headline:
Why Array BioPharma Inc. Sank 13.5% in May
Do Not Allow Advertisers to Use My Personal information
